TERT and central nervous system neoplasm: For the mutation status of the TERT promoter, the group of GBM patients with non-CNS tumors consisted of a higher proportion of the status of TERT promoter mutation than the other group (68.40% TERT promoter mutation status in the former group compared to 47.00% in the latter group, p = 0.034).